Evidence map›Paper›PMID 40688582›Full record

ArticleOncology letters2025

A FANCD2 gene mutation case analysis providing potential insights into the molecular mechanisms of gastric adenocarcinoma: A case report.

Kexin Zheng, Fengying Du, Yaodong Sang, Kangdi Dong, Kun Xiao, Ronghua Zhang, Changqing Jing, Liang Shang, Leping Li

Abstract readCase Reports
In one paragraph

Article in Oncology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kexin ZhengDepartment of Gastroenterological Surgery, Shandong Provincial Hospital, Shandong University, Jinan, Shandong 250021, P.R. China.
Fengying DuDepartment of Digestive Tumour Translational Medicine, Engineering Laboratory of Shandong Province, Shandong Provincial Hospital, Jinan, Shandong 250021, P.R. China.
Yaodong SangDepartment of Digestive Tumour Translational Medicine, Engineering Laboratory of Shandong Province, Shandong Provincial Hospital, Jinan, Shandong 250021, P.R. China.
Kangdi DongDepartment of Digestive Tumour Translational Medicine, Engineering Laboratory of Shandong Province, Shandong Provincial Hospital, Jinan, Shandong 250021, P.R. China.
Kun XiaoDepartment of Digestive Tumour Translational Medicine, Engineering Laboratory of Shandong Province, Shandong Provincial Hospital, Jinan, Shandong 250021, P.R. China.
Ronghua ZhangDepartment of Digestive Tumour Translational Medicine, Engineering Laboratory of Shandong Province, Shandong Provincial Hospital, Jinan, Shandong 250021, P.R. China.
Changqing JingDepartment of Gastroenterological Surgery, Shandong Provincial Hospital, Shandong University, Jinan, Shandong 250021, P.R. China.
Liang ShangDepartment of Gastroenterological Surgery, Shandong Provincial Hospital, Shandong University, Jinan, Shandong 250021, P.R. China.
Leping LiDepartment of Gastroenterological Surgery, Shandong Provincial Hospital, Shandong University, Jinan, Shandong 250021, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present case report describes the potential role of Fanconi anaemia complementation group D2 (

Indexed as

DNA repairFANCD2gastric cancergene mutationmolecular mechanism

Identifiers

PMID40688582
PMCPMC12273802

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.